%0 Journal Article
%T The effect of angiotensin-converting enzyme inhibitors on clinical
outcomes in patients with ischemic cardiomyopathy and midrange ejection
fraction: a post hoc subgroup analysis from the PEACE
trial
%A Allen Solomon
%A Gurusher Panjrath
%A John Tiu
%A Talal Alzahrani
%J Archive of "Therapeutic Advances in Cardiovascular Disease".
%D 2018
%R 10.1177/1753944718809266
%X There have been significant advances in the treatment of patients with cardiomyopathy with reduced ejection fraction (EF < 40%). However, there is a dearth of information in the treatment of patients with cardiomyopathy and midrange EF (40¨C50%). Current guidelines state to treat these patients similarly to patients with cardiomyopathy and preserved EF. Data from the Prevention of Events with Angiotensin-Converting Enzyme Inhibition (PEACE) trial were used to elucidate whether angiotensin-converting enzyme (ACE) inhibitors improve clinical outcomes in patients with ischemic cardiomyopathy and midrange EF
%K angiotensin-converting enzyme inhibitor
%K cardiomyopathy
%K midrange ejection fraction
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266248/